MedicaidPrior AuthMedium impact
Preauthorization Guidelines and Coverage Criteria for Spinraza (Nusinersen)
Maryland Medicaid·MD · Neurology, Pediatrics·Provider Transmittal
We identified it
Jun 20, 2026
Summary
I cannot analyze this policy change because the policy content sections (1 of 4 through 4 of 4) are empty. The policy appears to be about Spinraza (Nusinersen) preauthorization guidelines based on the title, but without the actual policy text, I cannot determine what specific changes are being made or their impact on billing operations.
Action Required
Contact the policy administrator or access the source URL (https://health.maryland.gov/mmcp/provider/Documents/PT_41-17.pdf) to obtain the complete policy content for Spinraza preauthorization guidelines. Review the full policy once available to determine specific billing and prior authorization requirements.